Allan Reine files SEC Form 4 disclosures for PIERIS PHARMACEUTICALS, INC.. They have made 2 open-market trades across 2 companies since 2017, most recently 2025-05-21.
CIK 0001714023
2 open-market purchases totalling $461K since 2017, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.